Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tina Tan

Editor-in-Chief

London, UK
Since she began covering the medtech industry in the late 1990s, Tina Tan has seen significant changes in the industry landscape: companies bulking up to become sector heavyweights, unwieldy conglomerates restructuring to get leaner, new players with game-changing technologies growing and thriving, struggling firms sadly fizzling into oblivion. She has also witnessed how the ever-evolving healthcare environment has impacted the way medical device companies operate, inciting them to develop new technologies – and services – to meet the needs of patient, physician and, of courses, the healthcare payer. As Editor, and prior to that Business Editor, of Clinica Medtech Intelligence, it is Tina’s experience and understanding of the key issues affecting medical device companies that has enabled her to maintain the high quality, business-critical content of Clinica for which the product is recognized globally. Tina has also dabbled in other sectors outside of medtech, having written for an eyewear fashion and an alternative health publication. But as attractive as it was to get cost-price Armani frames and free samples of organic root vegetables, Tina found herself being drawn back to the excitement of the medtech sector. Like many of her long-time colleagues covering this beat, she still marvels at the incredible gizmos and gadgets that are coming out from the industry, especially from the start-ups, and the genius creativity behind these potentially life-saving technologies.  
Advertisement
Set Alert for Articles By Tina Tan

Latest From Tina Tan

Change At Helm As Tissue Regenix Enters Next Growth Phase

Regenerative medicine firm Tissue Regenix is now seeking a new CEO following the departure of Anthony Odell. The change in leadership comes two months after the company made its maiden M&A deal, acquiring CellRight Technologies.

Regenerative Medicine Companies

Start-Up Spotlight: Lumicell, Shining The Light On Real-Time, Intraoperative Tumor Detection

With its coffers topped up and a new CEO in place, Lumicell is forging ahead with clinical trials of its LUM real-time, cancer imaging system, designed to improve the outcomes of surgical resection of tumors. The company's first target indication is for breast cancer and it is aiming for a US premarket approval in late Q1 of 2019.

Cancer Diagnostic Imaging

Will AAA's Nuclear Med Offerings Turn M&A Buzz Into A Deal?

Advanced Accelerator Applications (AAA) has hit the headlines with recent rumors of a potential acquisition deal from Novartis. Now that the radiopharmaceutical company has its first therapeutic product approved and ready for commercialization, is AAA really ready to sign the dotted line?

Cancer Companies

Device Week, Oct. 12, 2017 – Tomorrow's Technologies At The Medtech Conference; M&A Keeps A-Pace

In this edition of Device Week, find out which were the most interesting startups showcased at AdvaMed’s annual Medtech Conference, held at the end of September. Additionally, the last week has seen a surge in acquisition activity – which were the more notable deals that were cut?

Device Week M & A

Philips' Profit To Be Dented By FDA-Decreed AED Sales Halt

On signing a consent decree with the US FDA, Philips is halting manufacture and sales of external defibrillators produced at two facilities until the agency is satisfied the company is complying with current good manufacturing practice requirements. The suspension is expected to impact Philips' EBITA for the fourth quarter 2017 and for 2018.

Cardiology Compliance

Physidia Brings Home New Blood

Home hemodialysis specialist Physidia has appointed a new company president to take the business to grow commercialization of its S3 device.

Renal Appointments
See All
Advertisement
UsernamePublicRestriction

Register